{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:49:42Z","timestamp":1789750182255,"version":"4.0.1"},"reference-count":268,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["SGKJ-202502"],"award-info":[{"award-number":["SGKJ-202502"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174122"],"award-info":[{"award-number":["82174122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12023113"],"award-info":[{"award-number":["SHDC12023113"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189537","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:00:35Z","timestamp":1768582835000},"page":"189537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances"],"prefix":"10.1016","volume":"1881","author":[{"given":"Jiexiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0010","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189537_bb0025","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","article-title":"Neuroendocrine differentiation in prostate cancer requires ASCL1","volume":"84","author":"Rodarte","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0030","first-page":"1","article-title":"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol. Med."},{"issue":"7858","key":"10.1016\/j.bbcan.2026.189537_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6487","key":"10.1016\/j.bbcan.2026.189537_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"5930","key":"10.1016\/j.bbcan.2026.189537_bb0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0060","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189537_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-5-14","article-title":"Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues","volume":"5","author":"Singh","year":"2006","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0070","first-page":"336","article-title":"The occurrence of zinc in the human prostate gland","volume":"30","author":"Mawson","year":"1952","journal-title":"Can. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","article-title":"Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","article-title":"Tumour metabolism and its unique properties in prostate adenocarcinoma","volume":"17","author":"Bader","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0090","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1535-7163.MCT-23-0540","article-title":"A compound that inhibits glycolysis in prostate cancer controls growth of advanced prostate cancer","volume":"23","author":"Uo","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1541-7786.MCR-22-0250","article-title":"Subtype and site specific-induced metabolic vulnerabilities in prostate cancer","volume":"21","author":"Mossa","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112033","article-title":"Numb\/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation","volume":"42","author":"He","year":"2023","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094716","article-title":"Hexokinase 2 in cancer: a prima donna playing multiple characters","volume":"22","author":"Ciscato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2008.11.006","article-title":"Hexokinase-2 bound to mitochondria: cancer\u2019s stygian link to the \u201cWarburg Effect\u201d and a pivotal target for effective therapy","volume":"19","author":"Mathupala","year":"2009","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042165","article-title":"Hexokinase-2-linked glycolytic overload and unscheduled glycolysis-driver of insulin resistance and development of vascular complications of diabetes","volume":"23","author":"Rabbani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7150\/ijms.105553","article-title":"The role of HK2 in tumorigenesis and development: potential for targeted therapy with natural products","volume":"22","author":"He","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"41","key":"10.1016\/j.bbcan.2026.189537_bb0125","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.2174\/0929867326666181213092652","article-title":"Unlocking the potential of HK2 in cancer metabolism and therapeutics","volume":"26","author":"Garcia","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0130","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2014.07.053","article-title":"Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth","volume":"8","author":"Wang","year":"2014","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yexcr.2018.12.002","article-title":"Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1","volume":"374","author":"Xue","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/onc.2016.223","article-title":"Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten\/Tp53-deficient prostate cancer","volume":"36","author":"Martin","year":"2017","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0145","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/cas.15763","article-title":"Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency","volume":"114","author":"Zhao","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0150","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41467-019-10374-y","article-title":"Non-proteolytic ubiquitination of hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189537_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.680928","article-title":"Expression and clinical significance of HKII and HIF-1alpha in grade groups of prostate cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajur.2024.01.007","article-title":"LncRNA HCG18 promotes prostate cancer progression by regulating the miR-512-3p\/HK-2 axis","volume":"11","author":"Zhu","year":"2024","journal-title":"Asian J. Urol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.critrevonc.2014.05.007","article-title":"Phosphofructokinase: a mediator of glycolytic flux in cancer progression","volume":"92","author":"Al Hasawi","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7558","key":"10.1016\/j.bbcan.2026.189537_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14405","article-title":"Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations","volume":"523","author":"Webb","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","article-title":"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113426","article-title":"p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP","volume":"42","author":"Huang","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12943-024-02051-6","article-title":"A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0190","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1093\/nar\/gkab252","article-title":"Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2\/4-PFKP during tumorigenesis of advanced prostate cancer","volume":"49","author":"Xu","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/neuonc\/noac135","article-title":"Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy","volume":"25","author":"Lim","year":"2023","journal-title":"Neuro Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0200","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1007\/s11033-022-07513-y","article-title":"The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness","volume":"49","author":"Yan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbcan.2026.189537_bb0205","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","article-title":"Roles of PFKFB3 in cancer","volume":"2","author":"Shi","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030498","article-title":"Choosing kinase inhibitors for androgen deprivation therapy-resistant prostate cancer","volume":"14","author":"Zhong","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0215","first-page":"945","article-title":"PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis","volume":"52","author":"Peng","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"33","key":"10.1016\/j.bbcan.2026.189537_bb0220","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41388-022-02391-x","article-title":"PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma","volume":"41","author":"Thirusangu","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10238-024-01479-w","article-title":"Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance","volume":"24","author":"Lu","year":"2024","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-025-02056-8","article-title":"Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair","volume":"23","author":"Xiao","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tibs.2018.12.007","article-title":"Interconnection between metabolism and cell cycle in cancer","volume":"44","author":"Icard","year":"2019","journal-title":"Trends Biochem. Sci."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189537_bb0240","first-page":"5881","article-title":"High expression of inducible 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers","volume":"62","author":"Atsumi","year":"2002","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/2159-8290.CD-11-0234","article-title":"Functional metabolic screen identifies 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival","volume":"2","author":"Ros","year":"2012","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0250","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijrobp.2013.07.023","article-title":"Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer","volume":"87","author":"Ragnum","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12894-020-00635-0","article-title":"The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue","volume":"20","author":"Li","year":"2020","journal-title":"BMC Urol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1541-7786.MCR-15-0466","article-title":"The role of CD44 in glucose metabolism in prostatic small cell neuroendocrine carcinoma","volume":"14","author":"Li","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189537_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13402-018-0383-7","article-title":"Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target","volume":"41","author":"van Niekerk","year":"2018","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis","volume":"vol. 8","author":"Anastasiou","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189089","article-title":"Exploring the diverse role of pyruvate kinase M2 in cancer: navigating beyond glycolysis and the Warburg effect","volume":"1879","author":"Upadhyay","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189537_bb0285","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2026.189537_bb0290","article-title":"Glycolysis related lncRNA SNHG3 \/ miR-139-5p \/ PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance","volume":"260","author":"Yao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/07357907.2014.919306","article-title":"Changes in PKM2 associate with prostate cancer progression","volume":"32","author":"Wong","year":"2014","journal-title":"Cancer Invest."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0300","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s11307-018-1194-y","article-title":"The utility of [(18)F]DASA-23 for molecular imaging of prostate cancer with positron emission tomography","volume":"20","author":"Beinat","year":"2018","journal-title":"Mol. Imaging Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203745","article-title":"PKM2 and HIF-1alpha regulation in prostate cancer cell lines","volume":"13","author":"Hasan","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.bbcan.2026.189537_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.544288","article-title":"Pyruvate kinase M2 promotes prostate cancer metastasis through regulating ERK1\/2-COX-2 signaling","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101466","article-title":"Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)","volume":"59","author":"Xu","year":"2022","journal-title":"Mol. Metab."},{"issue":"7184","key":"10.1016\/j.bbcan.2026.189537_bb0320","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","article-title":"PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells","volume":"155","author":"Israelsen","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0330","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","article-title":"Facilitative glucose transporters: implications for cancer detection, prognosis and treatment","volume":"65","author":"Barron","year":"2016","journal-title":"Metabolism"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189537_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235811","article-title":"SGLT-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives","volume":"14","author":"Dutka","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2026.189537_bb0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0345","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.lungcan.2015.03.004","article-title":"Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer","volume":"88","author":"Osugi","year":"2015","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0350","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","article-title":"GLUT1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy","volume":"81","author":"Ancey","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0355","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0360","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2023.2283953","article-title":"Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma","volume":"18","author":"Hanbazazh","year":"2023","journal-title":"Libyan J. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0365","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/cas.13995","article-title":"Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer","volume":"110","author":"Sawayama","year":"2019","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0370","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s12276-024-01303-1","article-title":"CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer","volume":"56","author":"Shaha","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0375","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0380","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41419-022-05213-w","article-title":"FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis","volume":"13","author":"Cai","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0385","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00384-012-1610-8","article-title":"Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies","volume":"28","author":"Kapoor","year":"2013","journal-title":"Int. J. Color. Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0390","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/pros.23448","article-title":"GLUT1 regulates cell glycolysis and proliferation in prostate cancer","volume":"78","author":"Xiao","year":"2018","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0395","first-page":"1561","article-title":"Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score","volume":"20","author":"Stewart","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189537_bb0400","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.redox.2018.03.017","article-title":"GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress","volume":"17","author":"Gonzalez-Menendez","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2020.05.007","article-title":"GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers","volume":"485","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0410","article-title":"GLUT3\/SLC2A3 is an endogenous marker of hypoxia in prostate cancer cell lines and patient-derived xenograft tumors","volume":"12","author":"Ryniawec","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00432-015-1992-4","article-title":"Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes","volume":"142","author":"Vaz","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216179","article-title":"Glucose transporter 4: insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression","volume":"563","author":"Chang","year":"2023","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0425","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/cas.14865","article-title":"Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer","volume":"112","author":"Hoshi","year":"2021","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb0430","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1158\/0008-5472.CAN-19-0456","article-title":"Dietary fructose promotes prostate cancer growth","volume":"81","author":"Carreno","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0435","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/ERC-17-0051","article-title":"GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling","volume":"25","author":"White","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0440","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00424-020-02448-4","article-title":"SGLT2 and cancer","volume":"472","author":"Wright","year":"2020","journal-title":"Pflugers Arch."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189537_bb0445","article-title":"The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data","volume":"5","author":"Zheng","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189537_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1443045","article-title":"Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0455","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41467-023-36209-5","article-title":"Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice","volume":"14","author":"Yao","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189537_bb0465","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb0470","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/iub.1216","article-title":"Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy","volume":"65","author":"Miao","year":"2013","journal-title":"IUBMB Life"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0475","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189537_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216285","article-title":"NUSAP1-LDHA-glycolysis-lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma","volume":"567","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189537_bb0490","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.7150\/thno.53347","article-title":"KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091068","article-title":"Clinicopathological significance and prognostic value of lactate dehydrogenase A expression in gastric cancer patients","volume":"9","author":"Sun","year":"2014","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189537_bb0500","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s42255-022-00708-4","article-title":"Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189537_bb0505","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1158\/0008-5472.CAN-17-3226","article-title":"Aberrant FGFR tyrosine kinase signaling enhances the Warburg effect by reprogramming LDH isoform expression and activity in prostate cancer","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0510","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal. Transduct. Target Ther."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189537_bb0515","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.21873\/anticanres.15183","article-title":"Lactate dehydrogenase is a serum prognostic factor in clinically regional lymph node-positive prostate cancer","volume":"41","author":"Blas","year":"2021","journal-title":"Anticancer Res."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189537_bb0520","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1002\/cam4.3108","article-title":"Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: a meta-analysis","volume":"9","author":"Li","year":"2020","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0525","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clgc.2019.07.009","article-title":"Prognostic value of lactate dehydrogenase in metastatic prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Mori","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2017-0564","article-title":"Laboratory-based biomarkers and liver metastases in metastatic castration-resistant prostate cancer","volume":"23","author":"Cotogno","year":"2018","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0535","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12967-024-05193-9","article-title":"Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer","volume":"22","author":"Ye","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/ERC-18-0196","article-title":"ATM deficiency promotes progression of CRPC by enhancing Warburg effect","volume":"26","author":"Xu","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0545","first-page":"224","article-title":"Targeting lactate dehydrogenase-A promotes docetaxel-induced cytotoxicity predominantly in castration-resistant prostate cancer cells","volume":"42","author":"Muramatsu","year":"2019","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0550","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189537_bb0555","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0560","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00432-022-04371-w","article-title":"Metabolic changes during prostate cancer development and progression","volume":"149","author":"Beier","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0565","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0570","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the reverse Warburg effect in cancer: implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0580","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","article-title":"Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0585","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-023-10685-w","article-title":"NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189537_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111517","article-title":"Glycolysis inhibition and apoptosis induction in human prostate cancer cells by FV-429-mediated regulation of AR-AKT-HK2 signaling network","volume":"143","author":"Chen","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.911466","article-title":"PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation","volume":"12","author":"Song","year":"2022","journal-title":"Front. Oncol."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2026.189537_bb0600","article-title":"Low level exposure to BDE-47 facilitates the development of prostate cancer through TOP2A\/LDHA\/lactylation positive feedback circuit","volume":"263","author":"Tian","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbcan.2026.189537_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217441","article-title":"Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer","volume":"611","author":"Hindes","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0610","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189537_bb0615","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","article-title":"Immunotherapy of prostate cancer: facts and hopes","volume":"23","author":"Bilusic","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0620","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1186\/s12885-022-10239-6","article-title":"High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+\/regulatory T-cell infiltration","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0625","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cac2.12404","article-title":"Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2","volume":"43","author":"He","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189537_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133473","article-title":"Lactate as key metabolite in prostate cancer progression: what are the clinical implications?","volume":"15","author":"Chetta","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189537_bb0635","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.7150\/ijbs.85893","article-title":"Glycine decarboxylase (GLDC) plays a crucial role in regulating energy metabolism, invasion, metastasis and immune escape for prostate cancer","volume":"19","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189537_bb0640","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.7150\/jca.86940","article-title":"circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis","volume":"14","author":"Zhou","year":"2023","journal-title":"J. Cancer"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189537_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/nu16244338","article-title":"Curcumin and its potential to target the glycolytic behavior of lactate-acclimated prostate carcinoma cells with docetaxel","volume":"16","author":"Choi","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0650","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/bjc.2014.158","article-title":"Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy","volume":"110","author":"Koukourakis","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0655","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0660","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190880","article-title":"Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin","volume":"39","author":"Rai","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0665","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40170-021-00239-8","article-title":"Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells","volume":"9","author":"Almouhanna","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbcan.2026.189537_bb0670","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-9-33","article-title":"Warburg effect in chemosensitivity: targeting lactate dehydrogenase-a re-sensitizes taxol-resistant cancer cells to taxol","volume":"9","author":"Zhou","year":"2010","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0680","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12935-023-03042-1","article-title":"Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189537_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114741","article-title":"RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction","volume":"192","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119798","article-title":"MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis","volume":"282","author":"Zhou","year":"2021","journal-title":"Life Sci."},{"issue":"Pt B","key":"10.1016\/j.bbcan.2026.189537_bb0695","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","article-title":"HIF1alpha lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer","volume":"222","author":"Luo","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0700","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0705","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0710","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","article-title":"PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1","volume":"76","author":"Qian","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189537_bb0715","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2011.10.046","article-title":"IGF-1 induces hypoxia-inducible factor 1alpha-mediated GLUT3 expression through PI3K\/Akt\/mTOR dependent pathways in PC12 cells","volume":"1430","author":"Yu","year":"2012","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0720","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MPA.0b013e3181735ccb","article-title":"Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase\/Akt pathway in human pancreatic cancer cells","volume":"37","author":"Melstrom","year":"2008","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257090","article-title":"Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K\/Akt\/mTORC1-Hif1alpha axis","volume":"16","author":"Liu","year":"2021","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0730","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/mmr.2014.2888","article-title":"Roles of glucose transporter-1 and the phosphatidylinositol 3-kinase\/protein kinase B pathway in cancer radioresistance (review)","volume":"11","author":"Fang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189537_bb0735","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0740","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0745","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bph.13422","article-title":"The Warburg effect and drug resistance","volume":"173","author":"Bhattacharya","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0750","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189537_bb0755","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","article-title":"AMPK signaling and its targeting in cancer progression and treatment","volume":"85","author":"Hsu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0760","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12885-020-07286-2","article-title":"An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types","volume":"20","author":"Chang","year":"2020","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189537_bb0765","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-18-0585","article-title":"CAMKK2 promotes prostate cancer independently of AMPK via increased lipogenesis","volume":"78","author":"Penfold","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0770","first-page":"15","article-title":"Emerging roles of ADP-dependent glucokinase in prostate cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0775","first-page":"64","article-title":"ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression","volume":"10","author":"Xu","year":"2023","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0780","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgn032","article-title":"Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells","volume":"29","author":"Jung","year":"2008","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0785","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1158\/1535-7163.MCT-08-0631","article-title":"AMP-activated protein kinase promotes human prostate cancer cell growth and survival","volume":"8","author":"Park","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189537_bb0790","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-030-32656-2_10","article-title":"Prostate cancer energetics and biosynthesis","volume":"1210","author":"Lin","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb0795","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1007\/s12094-022-02874-z","article-title":"AMPK\u2019s double-faced role in advanced stages of prostate cancer","volume":"24","author":"Gharibpoor","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0800","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ebiom.2016.03.022","article-title":"Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer","volume":"7","author":"Wang","year":"2016","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0805","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1096\/fj.201701078R","article-title":"AMPK\/GSK3beta\/beta-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0810","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Ke","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0815","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189537_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145796","article-title":"Up-down regulation of HIF-1alpha in cancer progression","volume":"798","author":"Rashid","year":"2021","journal-title":"Gene"},{"issue":"7196","key":"10.1016\/j.bbcan.2026.189537_bb0825","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06905","article-title":"NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha","volume":"453","author":"Rius","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189537_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101892","article-title":"Co-culture with osteoblasts up-regulates glycolysis of chondrocytes through MAPK\/HIF-1 pathway","volume":"78","author":"Li","year":"2022","journal-title":"Tissue Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0835","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1073\/pnas.1816391116","article-title":"Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways","volume":"116","author":"Jia","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189537_bb0840","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/CMAR.S161762","article-title":"The association of HIF-1alpha expression with clinicopathological significance in prostate cancer: a meta-analysis","volume":"10","author":"Huang","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0845","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/07357907.2010.512595","article-title":"Knockdown of beta-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha","volume":"29","author":"Zhao","year":"2011","journal-title":"Cancer Invest."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0850","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10059-013-0096-8","article-title":"Epithelial-mesenchymal transition and migration of prostate cancer stem cells is driven by cancer-associated fibroblasts in an HIF-1alpha\/beta-catenin-dependent pathway","volume":"36","author":"Luo","year":"2013","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb0855","first-page":"1827","article-title":"beta-Catenin nuclear translocation induced by HIF-1alpha overexpression leads to the radioresistance of prostate cancer","volume":"52","author":"Luo","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189537_bb0860","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41388-023-02680-z","article-title":"Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer","volume":"42","author":"Cameron","year":"2023","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189537_bb0865","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.24.13.5923-5936.2004","article-title":"Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays","volume":"24","author":"Kim","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0870","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"34","key":"10.1016\/j.bbcan.2026.189537_bb0875","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/s41388-020-01389-7","article-title":"MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity","volume":"39","author":"Whitlock","year":"2020","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113221","article-title":"MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer","volume":"42","author":"Crowell","year":"2023","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb0885","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.764","article-title":"Inhibition of KDM4C\/c-Myc\/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism","volume":"12","author":"Lin","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb0890","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-23-0519","article-title":"Obesogenic high-fat diet and MYC cooperate to promote lactate accumulation and tumor microenvironment remodeling in prostate cancer","volume":"84","author":"Boufaied","year":"2024","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0895","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/s41418-022-00971-8","article-title":"Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis","volume":"29","author":"Han","year":"2022","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189537_bb0900","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","article-title":"PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect","volume":"9","author":"Gupta","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189537_bb0905","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46315","article-title":"A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model","volume":"8","author":"Wong","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0910","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8003","article-title":"BCAT1 overexpression regulates proliferation and c-Myc\/GLUT1 signaling in head and neck squamous cell carcinoma","volume":"45","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"7279","key":"10.1016\/j.bbcan.2026.189537_bb0915","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189537_bb0920","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/onc.2015.360","article-title":"Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters","volume":"35","author":"Gan","year":"2016","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189537_bb0925","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1158\/0008-5472.CAN-10-0740","article-title":"Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha","volume":"70","author":"Qing","year":"2010","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189537_bb0930","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189537_bb0940","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbcan.2026.189537_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107862","article-title":"Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4)","volume":"226","author":"Kobayashi","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2026.189537_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb0955","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189537_bb0960","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-11-312","article-title":"Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer","volume":"11","author":"Pertega-Gomes","year":"2011","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb0965","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb0970","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pros.24700","article-title":"Enhancing the anticancer effect of androgen deprivation therapy by monocarboxylate transporter 1 inhibitor in prostate cancer cells","volume":"84","author":"Kim","year":"2024","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb0975","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pros.22620","article-title":"Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer","volume":"73","author":"Pertega-Gomes","year":"2013","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189537_bb0980","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189537_bb0985","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-10-38","article-title":"The functional role of long non-coding RNA in human carcinomas","volume":"10","author":"Gibb","year":"2011","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0990","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-019-0776-8","article-title":"CircRNAs in cancer metabolism: a review","volume":"12","author":"Yu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb0995","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-018-0648-7","article-title":"Emerging roles of long non-coding RNAs in tumor metabolism","volume":"11","author":"Sun","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189537_bb1000","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biocel.2018.07.003","article-title":"Roles of microRNA in prostate cancer cell metabolism","volume":"102","author":"Kasomva","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189537_bb1005","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.2147\/CMAR.S257441","article-title":"Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p\/HK2 Axis","volume":"12","author":"Du","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113149","article-title":"METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1\/c-Myc axis","volume":"416","author":"Liu","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4149\/neo_2022_211021N1497","article-title":"LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer","volume":"69","author":"Xia","year":"2022","journal-title":"Neoplasma"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11010-021-04284-1","article-title":"STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression","volume":"477","author":"Zhu","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189537_bb1025","article-title":"lncRNA-DANCR promotes taxol resistance of prostate cancer cells through modulating the miR-33b-5p-LDHA Axis","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1030","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12395","article-title":"LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2","volume":"50","author":"Wang","year":"2017","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3892\/or.2017.5430","article-title":"Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b\/HK2 axis","volume":"37","author":"Tao","year":"2017","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb1040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41388-022-02178-0","article-title":"MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer","volume":"41","author":"Cannistraci","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189537_bb1045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biocel.2016.01.018","article-title":"A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells","volume":"73","author":"Meng","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1050","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1080\/21655979.2022.2037367","article-title":"Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1055","doi-asserted-by":"crossref","DOI":"10.1111\/and.14406","article-title":"Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1","volume":"54","author":"Ding","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.bbcan.2026.189537_bb1060","doi-asserted-by":"crossref","first-page":"11289","DOI":"10.2147\/OTT.S272294","article-title":"Circ_0057553\/miR-515-5p regulates prostate cancer cell proliferation, apoptosis, migration, invasion and aerobic glycolysis by targeting YES1","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189537_bb1065","doi-asserted-by":"crossref","DOI":"10.1111\/and.14227","article-title":"CircRNA pappalysin 1 facilitates prostate cancer development through miR-515-5p\/FKBP1A axis","volume":"53","author":"Wang","year":"2021","journal-title":"Andrologia"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10585-024-10314-1","article-title":"Downregulation of hsa_circ_0006620 inhibits the malignant progression of prostate cancer by regulation of the miR-502-3p\/HK2 axis mediated by aerobic glycolysis","volume":"41","author":"Jin","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1075","first-page":"70","article-title":"CircSMARCA5 facilitates the progression of prostate cancer through miR-432\/PDCD10 Axis","volume":"36","author":"Dong","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bbcan.2026.189537_bb1080","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8693259","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR Axis","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb1085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/2211-5463.12086","article-title":"miR-132 mediates a metabolic shift in prostate cancer cells by targeting Glut1","volume":"6","author":"Qu","year":"2016","journal-title":"FEBS Open Bio"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1090","first-page":"2056","article-title":"MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010617","article-title":"A proteomic approach reveals that miR-423-5p modulates glucidic and amino acid metabolism in prostate cancer cells","volume":"24","author":"Luce","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189537_bb1100","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/2211-5463.12718","article-title":"MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3","volume":"9","author":"Wang","year":"2019","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41389-022-00385-8","article-title":"miR-32 promotes MYC-driven prostate cancer","volume":"11","author":"Scaravilli","year":"2022","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1110","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3892\/or.2017.5852","article-title":"miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer","volume":"38","author":"Ling","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1115","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4149\/neo_2022_220626N665","article-title":"Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway","volume":"69","author":"Dai","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbcan.2026.189537_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112338","article-title":"The glycolysis-related AMPK\/ULK signaling pathway mediates the inhibitory effect of adiponectin in prostate cancer cells","volume":"593","author":"Yang","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12672-023-00740-0","article-title":"beta-Arrestin2 promotes docetaxel resistance of castration-resistant prostate cancer via promoting hnRNP A1-mediated PKM2 alternative splicing","volume":"14","author":"Zhou","year":"2023","journal-title":"Discov. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb1130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.20892\/j.issn.2095-3941.2020.0583","article-title":"IL13Ralpha1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation","volume":"19","author":"Feng","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189537_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2025.112459","article-title":"EDNRB negatively regulates glycolysis to exhibit anti-tumor functions in prostate cancer by cGMP\/PKG pathway","volume":"598","author":"Li","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1140","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14830","article-title":"Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer","volume":"29","author":"Qian","year":"2022","journal-title":"Int. J. Urol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189537_bb1145","article-title":"HO-1 modulates aerobic glycolysis through LDH in prostate cancer cells","volume":"10","author":"Cascardo","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bbcan.2026.189537_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155185","article-title":"Targeted metabolomics reveals PFKFB3 as a key target for elemene-mediated inhibition of glycolysis in prostate cancer cells","volume":"123","author":"Dong","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-022-00797-z","article-title":"Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference","volume":"29","author":"Fu","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189537_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107139","article-title":"Tanshinone analog inhibits castration-resistant prostate cancer cell growth by inhibiting glycolysis in an AR-dependent manner","volume":"300","author":"Yu","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189537_bb1165","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/carcin\/bgz155","article-title":"Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane","volume":"40","author":"Singh","year":"2019","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb1170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.31310","article-title":"Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model","volume":"143","author":"Qu","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb1175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ptr.7631","article-title":"Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation","volume":"37","author":"Hu","year":"2023","journal-title":"Phytother. Res."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189537_bb1180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813912","article-title":"The apoptotic and anti-Warburg effects of brassinin in PC-3 cells via reactive oxygen species production and the inhibition of the c-Myc, SIRT1, and beta-catenin signaling Axis","volume":"24","author":"Kwon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189537_bb1185","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7626405","article-title":"ERK1\/2-dependent inhibition of glycolysis in curcumin-induced cytotoxicity of prostate carcinoma cells","volume":"2022","author":"Lee","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2026.189537_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116730","article-title":"Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K\/AKT pathway and downregulating HIF-1alpha expression","volume":"233","author":"Zhu","year":"2019","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189537_bb1195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215384","article-title":"The molecular effects of sulforaphane and capsaicin on metabolism upon androgen and Tip60 activation of androgen receptor","volume":"20","author":"Carrasco-Pozo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1200","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ptr.8115","article-title":"Inhibition of glycolysis and SIRT1\/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells","volume":"38","author":"Park","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bbcan.2026.189537_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111393","article-title":"Prostate cancer-selective anticancer action of an oxindole derivative via HO-1-mediated disruption of metabolic reprogramming","volume":"408","author":"Ghimire","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189537_bb1210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095269","article-title":"Exploiting the metabolic consequences of PTEN loss and Akt\/hexokinase 2 hyperactivation in prostate cancer: a new role for delta-tocotrienol","volume":"23","author":"Fontana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.bbcan.2026.189537_bb1215","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1021\/acs.jafc.9b03875","article-title":"Inorganic selenium induces nonapoptotic programmed cell death in PC-3 prostate cancer cells associated with inhibition of glycolysis","volume":"67","author":"Cui","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010265","article-title":"Novel specific pyruvate kinase M2 inhibitor, compound 3h, induces apoptosis and autophagy through suppressing Akt\/mTOR signaling pathway in LNCaP cells","volume":"15","author":"Jiang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2021.03.033","article-title":"CD4(+) T-cell differentiation and function: unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria","volume":"148","author":"Almeida","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12964-024-01493-1","article-title":"1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1\/PKM2\/LDHB axis","volume":"22","author":"Chang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189537_bb1235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1037341","article-title":"Targeting glycolysis in non-small cell lung cancer: promises and challenges","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41523-023-00598-z","article-title":"PI3K\/AKT signaling activates HIF1alpha to modulate the biological effects of invasive breast cancer with microcalcification","volume":"9","author":"Tian","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb1250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189537_bb1255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/wrr.13067","article-title":"PI3K\/AKT pathway promotes keloid fibroblasts proliferation by enhancing glycolysis under hypoxia","volume":"31","author":"Wang","year":"2023","journal-title":"Wound Repair Regen."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41540-025-00525-x","article-title":"Computational modeling of cancer cell metabolism along the catabolic-anabolic axes","volume":"11","author":"Villela-Castrejon","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189537_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031155","article-title":"Cancer as a metabolic disorder","volume":"23","author":"Gyamfi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189537_bb1275","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1069555","article-title":"Proton-coupled monocarboxylate transporters in cancer: from metabolic crosstalk, immunosuppression and anti-apoptosis to clinical applications","volume":"10","author":"Duan","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189537_bb1280","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2147\/CMAR.S421771","article-title":"Role of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4) in tumor cells and the tumor microenvironment","volume":"15","author":"Liu","year":"2023","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7150\/thno.51631","article-title":"The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential","volume":"11","author":"Contreras-Lopez","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab."},{"issue":"52","key":"10.1016\/j.bbcan.2026.189537_bb1295","doi-asserted-by":"crossref","first-page":"18697","DOI":"10.1073\/pnas.1415669112","article-title":"A long noncoding RNA connects c-Myc to tumor metabolism","volume":"111","author":"Hung","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189537_bb1300","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.7150\/ijbs.40769","article-title":"LncRNAs regulate metabolism in cancer","volume":"16","author":"Lin","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1305","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-022-02252-1","article-title":"TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1alpha degradation","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1310","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189537_bb1315","article-title":"Natural products targeting glycolysis in cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9\u201310","key":"10.1016\/j.bbcan.2026.189537_bb1320","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s10495-024-01952-7","article-title":"Metabolic heterogeneity and potential immunotherapeutic responses revealed by single-cell transcriptomics of breast cancer","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2026.189537_bb1325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101396","article-title":"Toward modeling metabolic state from single-cell transcriptomics","volume":"57","author":"Hrovatin","year":"2022","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189537_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910503","article-title":"The use of patient-derived organoids in the study of molecular metabolic adaptation in breast cancer","volume":"25","author":"Glibetic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189537_bb1340","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40170-024-00357-z","article-title":"Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles","volume":"12","author":"Ali","year":"2024","journal-title":"Cancer Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:29:54Z","timestamp":1782030594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":268,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000090"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189537","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189537"}}